STTK
Price
$4.76
Change
-$0.11 (-2.26%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
373.43M
64 days until earnings call
Intraday BUY SELL Signals
TNYA
Price
$0.79
Change
-$0.00 (-0.00%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
171.43M
70 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

STTK vs TNYA

Header iconSTTK vs TNYA Comparison
Open Charts STTK vs TNYABanner chart's image
STTK vs TNYA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
STTK vs. TNYA commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STTK is a Buy and TNYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (STTK: $4.87 vs. TNYA: $0.79)
Brand notoriety: STTK and TNYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STTK: 157% vs. TNYA: 134%
Market capitalization -- STTK: $373.43M vs. TNYA: $171.43M
STTK [@Biotechnology] is valued at $373.43M. TNYA’s [@Biotechnology] market capitalization is $171.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STTK’s FA Score shows that 0 FA rating(s) are green whileTNYA’s FA Score has 0 green FA rating(s).

  • STTK’s FA Score: 0 green, 5 red.
  • TNYA’s FA Score: 0 green, 5 red.
According to our system of comparison, both STTK and TNYA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STTK’s TA Score shows that 4 TA indicator(s) are bullish while TNYA’s TA Score has 6 bullish TA indicator(s).

  • STTK’s TA Score: 4 bullish, 6 bearish.
  • TNYA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TNYA is a better buy in the short-term than STTK.

Price Growth

STTK (@Biotechnology) experienced а -20.29% price change this week, while TNYA (@Biotechnology) price change was +1.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.03%. For the same industry, the average monthly price growth was -2.51%, and the average quarterly price growth was +2.77%.

Reported Earning Dates

STTK is expected to report earnings on Aug 06, 2026.

TNYA is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STTK($373M) has a higher market cap than TNYA($171M). STTK YTD gains are higher at: 33.425 vs. TNYA (11.033). STTK has higher annual earnings (EBITDA): -49.02M vs. TNYA (-78.32M). STTK has more cash in the bank: 90.4M vs. TNYA (80.9M). STTK has less debt than TNYA: STTK (2.89M) vs TNYA (10.1M). STTK has higher revenues than TNYA: STTK (1M) vs TNYA (225K).
STTKTNYASTTK / TNYA
Capitalization373M171M218%
EBITDA-49.02M-78.32M63%
Gain YTD33.42511.033303%
P/E RatioN/AN/A-
Revenue1M225K444%
Total Cash90.4M80.9M112%
Total Debt2.89M10.1M29%
TECHNICAL ANALYSIS
Technical Analysis
STTKTNYA
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
STTK
Daily Signal:
Gain/Loss:
TNYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAEGX18.080.02
+0.11%
BlackRock Unconstrained Equity Instl
BCVCX39.97N/A
N/A
Sterling Capital Behav Lg Cp Val Eq C
FGEMX139.74N/A
N/A
Fidelity Advisor Communication ServicesM
RRFDX42.51N/A
N/A
T. Rowe Price Equity Income R
FCGBX3.11N/A
N/A
Templeton Global Dynamic Income C

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with VRTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
-13.81%
VRTX - STTK
36%
Loosely correlated
-3.04%
ADCT - STTK
35%
Loosely correlated
-6.76%
GOSS - STTK
31%
Poorly correlated
+1.01%
TNYA - STTK
31%
Poorly correlated
-9.20%
ZLAB - STTK
30%
Poorly correlated
+0.41%
More

TNYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNYA has been loosely correlated with CDXS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNYA jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNYA
1D Price
Change %
TNYA100%
-9.20%
CDXS - TNYA
41%
Loosely correlated
+0.94%
VCYT - TNYA
40%
Loosely correlated
-0.79%
ABEO - TNYA
38%
Loosely correlated
+1.15%
TCRX - TNYA
37%
Loosely correlated
-2.89%
ANIX - TNYA
37%
Loosely correlated
-5.00%
More